Intraventricular topotecan in the successful treatment of recurrent CNS pleuropulmonary blastoma

被引:0
|
作者
Shim, Jenny [1 ,2 ]
Reisner, Andrew [1 ,3 ]
Esiashvili, Natia [4 ]
Rapkin, Louis [5 ]
Olson, Thomas [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[2] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[3] Emory Univ, Sch Med, Dept Neurosurg Pediat, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA
[5] Childrens Hosp Pittsburgh, Dept Oncol, Pittsburgh, PA 15213 USA
关键词
CNS metastasis; intraventricular topotecan; pleuropulmonary blastoma; PROGNOSTIC-FACTORS; CHILDREN;
D O I
10.1002/pbc.29529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pleuropulmonary blastoma (PPB) is a rare pediatric tumor of the pleura and pulmonary mesenchyme, associated with pathogenic germline DICER1 mutations. Although the most common site of metastasis is the central nervous system (CNS), patients with CNS metastasis have dismal outcome. We report a case of a patient presenting with type II PPB and intracranial and bone metastases. We describe a multimodal therapy approach and highlight the use of intraventricular topotecan for isolated CNS recurrence. In addition, a new pathogenic germline mutation heterozygous for the c.1234delT of DICER1 was identified. Patient remains in remission 3 years after recurrence.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
    Rubenstein, James L.
    Li, Jing
    Chen, Lingjing
    Advani, Ranjana
    Drappatz, Jan
    Gerstner, Elizabeth
    Batchelor, Tracy
    Krouwer, Hendrikus
    Hwang, James
    Auerback, Glenna
    Kadoch, Cigall
    Lowell, Clifford
    Munster, Pamela
    Cha, Soonmee
    Shuman, Marc A.
    Damon, Lloyd E.
    BLOOD, 2013, 121 (05) : 745 - 751
  • [22] Topotecan/ifosfamide protocol for treatment of CNS involvement of solid tumors
    Kiewe, P.
    Reinwald, M.
    Thiel, E.
    Korfel, A.
    ONKOLOGIE, 2010, 33 : 65 - 65
  • [23] Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
    Paton, F.
    Paulden, M.
    Saramago, P.
    Manca, A.
    Misso, K.
    Palmer, S.
    Eastwood, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 55 - 62
  • [24] Update on the role of topotecan in the treatment of recurrent ovarian cancer
    Herzog, TJ
    ONCOLOGIST, 2002, 7 : 3 - 10
  • [25] Case studies of patients receiving intraventricular topotecan for treatment of neoplastic meningitis.
    Walker, J. G.
    Schultz, D. L.
    Grisdale, K. A.
    Groves, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child
    Akyuz, Canan
    Aydin, G. Burca
    Cila, Aysenur
    Akalan, Nejat
    Soylemezoglu, Figen
    Cengiz, Mustafa
    Yazici, Nalan
    Buyukpamukcu, Munevver
    LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1253 - 1255
  • [27] Successful neuroendoscopic treatment of intraventricular brain abscess rupture
    Nishizaki, Takafumi
    Ikeda, Norio
    Nakano, Shigeki
    Sakakura, Takanori
    Abiko, Masaru
    Okamura, Tomomi
    CLINICS AND PRACTICE, 2011, 1 (03) : 105 - 106
  • [28] Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer
    Huinink, WTB
    Gore, M
    Carmichael, J
    Gordon, A
    Malfetano, J
    Hudson, I
    Broom, C
    Scarabelli, C
    Davidson, N
    Spanczynski, M
    Bolis, G
    Malmstrom, H
    Coleman, R
    Fields, SC
    Heron, JF
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2183 - 2193
  • [29] Topotecan in the treatment of recurrent small-cell lung cancer
    Denisso, Tadeusz
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (03): : 99 - 104
  • [30] Phase I study of intraventricular administration of rituximab in patients with recurrent intraocular and CNS lymphoma
    Rubenstein, J
    O'Brien, J
    Shuman, M
    Abrey, L
    Combs, D
    O'Connor, P
    ANNALS OF ONCOLOGY, 2005, 16 : 68 - 68